Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 55154-8335

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-8335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of Mirtazapine, showing its characteristic fused ring system and nitrogen atoms.*
FDA Label Image

15mg Bag Label (04494335 Fcd8 47b2 A573 98a214f07ff6 00)

15mg Bag Label (04494335 Fcd8 47b2 A573 98a214f07ff6 00)
Label for Mirtazapine orally disintegrating tablets, USP 15 mg, in a 6 unit dose blister pack. The label lists inactive ingredients, storage conditions, removal instructions, and warnings. Distributed by Aurobindo Pharma USA, Inc., made in India, and distributed by Cardinal Health. The product NDC is 55154-8335-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.